Literature DB >> 8786298

Glucocorticoids promote a TH2 cytokine response by CD4+ T cells in vitro.

F Ramírez1, D J Fowell, M Puklavec, S Simmonds, D Mason.   

Abstract

Purified rat CD4+ T cells were activated in vitro in the presence or absence of the glucocorticoid dexamethasone. They were then expanded in IL-2 and subsequently restimulated, this time in the absence of the hormone. The results indicate that the exposure of the cells to dexamethasone in the primary stimulation changed the cytokine synthesis induced by the secondary stimulation. The mRNA levels for IL-4, IL-10, and IL-13 were all increased by the pretreatment, whereas synthesis of IFN-gamma and TNF-alpha was diminished. Further studies in which IL-4 was used together with dexamethasone showed that the cytokine potentiated the effect of the hormone. These data suggest that the neuroendocrine system can influence the cytokine response to pathogens and autoantigens in a way that favors Th2-type reactions. There are similar implications for therapy with glucocorticoids, and these drugs may be expected to have long term immunologic effects as well as short-lived immunosuppressive ones. The production of a mouse mAb, MRC-OX81, against rat IL-4 is also described.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8786298

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  79 in total

1.  The role of endogenous steroid hormones in the generation of T helper 2-mediated autoimmunity in mercuric chloride-treated Brown-Norway rats.

Authors:  I A MacPhee; D R Turner; D B Oliveira
Journal:  Immunology       Date:  2000-01       Impact factor: 7.397

2.  Mycobacterial glycolipid cord factor trehalose 6,6'-dimycolate causes a decrease in serum cortisol during the granulomatous response.

Authors:  Jeffrey K Actor; Jessica Indrigo; Christopher M Beachdel; Margaret Olsen; Alice Wells; Robert L Hunter; Amitava Dasgupta
Journal:  Neuroimmunomodulation       Date:  2002 -2003       Impact factor: 2.492

Review 3.  Role of cytokines in the pathogenesis of autoimmune diabetes mellitus.

Authors:  Alex Rabinovitch; Wilma L Suarez-Pinzon
Journal:  Rev Endocr Metab Disord       Date:  2003-09       Impact factor: 6.514

4.  Cellular immune activation in Gulf War veterans.

Authors:  Anna Skowera; Matthew Hotopf; Elzbieta Sawicka; Ruben Varela-Calvino; Catherine Unwin; Vasilis Nikolaou; Lisa Hull; Khalida Ismail; Anthony S David; Simon C Wessely; Mark Peakman
Journal:  J Clin Immunol       Date:  2004-01       Impact factor: 8.317

Review 5.  Immunopathology and biology-based treatment of steroid-refractory graft-versus-host disease.

Authors:  Tomomi Toubai; John Magenau
Journal:  Blood       Date:  2020-07-23       Impact factor: 22.113

6.  Plasma cytokine changes in relation to exercise intensity and muscle damage.

Authors:  Jonathan M Peake; Katsuhiko Suzuki; Matthew Hordern; Gary Wilson; Kazunori Nosaka; Jeff S Coombes
Journal:  Eur J Appl Physiol       Date:  2005-09-06       Impact factor: 3.078

7.  Immunological dysfunction, vaccination and Gulf War illness.

Authors:  Mark Peakman; Ania Skowera; Matthew Hotopf
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-04-29       Impact factor: 6.237

8.  Antinuclear autoantibodies (ANA) in Gulf War-related illness and chronic fatigue syndrome (CFS) patients.

Authors:  A Skowera; E Stewart; E T Davis; A J Cleare; C Unwin; L Hull; K Ismail; G Hossain; S C Wessely; M Peakman
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

9.  Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy.

Authors:  M Comabella; K Balashov; S Issazadeh; D Smith; H L Weiner; S J Khoury
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

10.  The effects of androstenediol and dehydroepiandrosterone on the course and cytokine profile of tuberculosis in BALB/c mice.

Authors:  R Hernandez-Pando; M De La Luz Streber; H Orozco; K Arriaga; L Pavon; S A Al-Nakhli; G A Rook
Journal:  Immunology       Date:  1998-10       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.